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Skeletal muscle contractile function declines with aging, disease, and disuse. In vivo
muscle contractile function depends on a variety of factors, but force, contractile
velocity and power generating capacity ultimately derive from the summed contribution
of single muscle fibers. The contractile performance of these fibers are, in turn,
dependent upon the isoform and function of myofilament proteins they express, with
myosin protein expression and its mechanical and kinetic characteristics playing a
predominant role. Alterations in myofilament protein biology, therefore, may contribute
to the development of functional limitations and disability in these conditions. Recent
studies suggest that these conditions are associated with altered single fiber performance
due to decreased expression of myofilament proteins and/or changes in myosin-actin
cross-bridge interactions. Furthermore, cellular and myofilament-level adaptations are
related to diminished whole muscle and whole body performance. Notably, the effect
of these various conditions on myofilament and single fiber function tends to be
larger in older women compared to older men, which may partially contribute to their
higher rates of disability. To maintain functionality and provide the most appropriate and
effective countermeasures to aging, disease, and disuse in both sexes, a more thorough
understanding is needed of the contribution of myofilament adaptations to functional
disability in older men and women and their contribution to tissue level function and
mobility impairment.
Keywords: myosin, actin, cross-bridge kinetics, single fiber, isometric tension, contractile velocity, sex differences,
physical activity
INTRODUCTION
Aging, disease, and disuse decrease whole skeletal muscle con-
tractile performance, which reduces an individual’s ability to
accomplish tasks associated with daily living, eventually leading
to physical disability (Guralnik et al., 1995; Janssen et al., 2002;
Kortebein et al., 2008). Knowledge of the mechanisms underlying
the loss of skeletal muscle performance will aid in the develop-
ment of suitable exercise and pharmacological countermeasures
to forestall or counteract these detrimental changes.
Whole muscle contractile performance has been identified
as an important determinant of functional limitations in older
adults (Reid and Fielding, 2012). As whole muscle performance is
dependent upon the functional character of single muscle fibers
(Harridge et al., 1996; D’Antona et al., 2006), which are, in turn,
largely determined by the type of myofilament proteins they
express and their function (Bottinelli, 2001), alterations inmyofil-
ament protein biology may contribute to the development of
disability in these conditions. Unfortunately, myofilament prop-
erties cannot be discerned from measurements performed at the
whole muscle level due to methodological limitations (e.g., esti-
mation of muscle size, muscle architecture), subjective factors
(e.g., volitional effort) and the interceding effects of other physio-
logical systems that regulate whole muscle function (e.g., neural,
excitation-contraction coupling, connective tissue properties).
That is, because myofilaments are the end effectors of muscle
contraction, the interceding effects of higher order regulatory
factors (i.e., at the cellular, tissue or organ/tissue systems level)
can mask variation in myofilament function. Thus, to reliably
assess the effects of aging, disease, and disuse on skeletal mus-
cle myofilament biology, a reductionist approach is required,
where measurements are obtained at the cellular and molecular
levels.
This review will focus on human studies that have examined
skeletal muscle myofilament structure and function at the cel-
lular and/or molecular levels. As aging, disease, and disuse may
alter muscle structure or function by changing muscle quantity
[i.e., cross-sectional area (CSA) and/or amount of mass per unit
muscle size] or quality (i.e., performance per unit muscle size),
we will specifically address these variables in each condition. The
review is organized based upon a continuum of wholemuscle per-
formance we have observed in our laboratories, which indicates
that aging reduces wholemuscle performance, both isometric and
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isokinetic, with progressively larger reductions associated with
decreasing activity level, the presence of acute or chronic disease
and finally profound, protracted muscle disuse (Figure 1). The
reader is referred to several recent reviews of other important
aspects of the neuromuscular system that undoubtedly conspire
with myofilament adaptations to contribute to functional impair-
ments with aging, disease, and disuse (Raj et al., 2010; Rehn et al.,
2012; Reid and Fielding, 2012; Russ et al., 2012; Calvani et al.,
2013).
MYOSIN-ACTIN CROSS-BRIDGE (XB) INTERACTIONS
The formation of the myosin-actin XB is the end effector of
muscle contraction. This interaction of two myofilament pro-
teins, myosin and actin, dictate single fiber force and contractile
velocity, which can be summarized into simple equations by
making several assumptions about the myosin-actin interaction:
(1) myosin is either strongly bound to actin producing force or
detached from actin producing no force and (2) the XB behaves
as a Hookian spring, as detailed (Palmer et al., 2007). In brief,
the amount of force that can be produced by a half-sarcomere
during isometric contraction can be represented as the num-
ber of strongly-bound XBs multiplied by the force generated
per XB (Funi) (Huxley, 1957; Brenner, 1988). The number of
FIGURE 1 | Whole leg muscle contractile performance changes with
aging, disease, and disuse. Young (open bars) and older (closed bars) are
arranged such that whole muscle performance progressively decreases to
the right along the x-axis. Volunteers identified as “Young” and “Mod
active” are from Miller et al. (2013), “Active” and “Disuse” are from
Callahan et al. (2014b), “Inactive” and “Heart” are from Toth et al. (2012),
and “Cancer” are from Toth et al. (2013). Isokinetic torque measurements
were collected at 60◦/s. Mod, moderately; Heart, Heart failure.
strongly-bound XBs at any point in time is a function of the total
number of functionalmyosin heads (N)multiplied by the fraction
of time a strongly-bound XB is formed (ton) as a function of total
myosin cycle time (ton + toff), where ton is the amount of time
myosin is strongly bound to actin and toff is the amount of time
myosin is detached from actin. Accordingly, the amount of force
that can be produced by the half-sarcomere during isometric ten-
sion can be written as: N (ton/(ton + toff)) Funi. Notably, ton/(ton +
toff) is commonly called the myosin duty ratio and, although dif-
ficult to measure, may be altered under various circumstances,
with this effect perhaps best exemplified by differences between
themyosin isoforms found in human skeletal muscle (Linari et al.,
2004). The force generated per XB may also be altered and can
be represented as the elastic stiffness of the XB (kstiff) multi-
plied by the unitary displacement of the myosin power stroke
(duni). Contractile velocity is represented most simply as duni
divided by ton, in agreement with single fiber findings showing
faster velocities with shorter ton (i.e., higher myosin detachment
rate) (Piazzesi et al., 2007). Although controversial, recent exper-
imental and modeling work indicates that velocity is also faster
with shorter toff (i.e., higher myosin attachment rate) (Hooft
et al., 2007; Walcott et al., 2012), potentially via mechanisms that
ultimately shorten ton (Walcott et al., 2012). Considered in this
context, aging, disease, and/or disuse could alter skeletal mus-
cle force production or velocity by altering the interaction of
myosin and actin, which would ultimately affect whole muscle
performance and functional capabilities.
What is the relative importance of XB kinetics (e.g., ton
and toff) vs. XB mechanical properties (e.g., Funi and duni) in
determining single fiber function? Single myosin molecule stud-
ies comparing myosin heavy chain (MHC) isoforms between
[smooth from turkey vs. skeletal from chicken (Guilford et al.,
1997)] and within [α vs. β cardiac in rabbit (Palmiter et al., 1999)
and rat (Sugiura et al., 1998)] species have shown no differences
in Funi or duni, indicating that isoform differences in force and
velocity are due primarily to alterations in XB kinetics. In support
of XB kinetics being the primary determinants of fiber func-
tion, frog single fiber experiments within a single isoform show
that Funi and duni remain consistent over a range of velocities
(Piazzesi et al., 2007). In contrast, when looking across fiber types,
human single fiber experiments indicate that both XB kinetics
and Funi are responsible for the higher forces generated by faster
contracting MHC isoforms (Linari et al., 2004). Similarly, single
fiber (Brenner et al., 2012) and single molecule (Capitanio et al.,
2006) measurements comparing slow isoforms from one species
to fast isoforms from another species indicate faster MHC iso-
forms have higher XB stiffness (kstiff), most likely resulting in a
higher Funi. However, these isoform differencesmay potentially be
due to normal sequence variations as isolatedmyosin from animal
species varying in body size contract at distinctly different veloci-
ties (Pellegrino et al., 2003). Overall, these results indicate that XB
kinetics play an important role in setting both force and velocity
in single muscle fibers, while the role of XB mechanical prop-
erties is not clearly defined. Thus, the evaluation of XB kinetics
and mechanics as mediators of cellular and tissue level contractile
function remains an important area of future study, especially in
humans.
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Alterations in single fiber force and velocity can also occur
via changes in muscle quantity and/or structure. Human skele-
tal muscle fibers contains three different isoforms (I, IIA, or IIX),
with individual fibers expressing either one or multiple isoforms
leading to six different fiber types (I, I/IIA, IIA, IIA/IIX, IIX,
I/IIA/IIX), with pure MHC I and IIA being the two most preva-
lent. Parenthetically, an additional embryonic isoform of myosin
may be expressed in some physiological/pathophysiological con-
ditions (D’Antona et al., 2003, 2006). A simple shift in the type
of MHC isoform expressed in the fiber will produce different
tissue level velocity and tension (force per CSA) characteris-
tics, as faster contracting MHCs (I < IIA < IIX) produce more
tension (D’Antona et al., 2003, 2006; Pansarasa et al., 2009;
Krivickas et al., 2011). Thus, this myofilament variation can alter
whole muscle performance (Thorstensson et al., 1977; Ryushi and
Fukunaga, 1986; Harridge et al., 1996). In addition to changes
in MHC isoform, reducing the amount of myofilament proteins
by having smaller fiber CSA, reduced myofibrillar fractional area
(e.g., less myofibril area due to an increase in inter-myofibrillar
space or other non-contractile elements), or the removal of thick
(myosin containing) or thin (actin containing) filaments would
decrease single fiber force production. Myofilament ultrastruc-
ture plays an important role in setting contractile performance
by providing the framework for XB interactions. For instance, at
the fiber level, the amount of isometric force produced is equal
to the total number of heads interacting in each half-sarcomere
(each half-sarcomere must produce identical forces or the sar-
comere will change its length). Thus, removal of myosin heads,
either from the ends of the thick filament or randomly through-
out the thick filament, or a reduction in the number of thin
filaments would reduce the number of heads able to interact in
a half-sarcomere and result in lower force production. Although
fiber CSA is commonly measured in healthy adults as well as
during aging, disuse, and disease, changes in myofilament pro-
tein content and ultrastructure have not been routinely examined,
especially in combination with contractile measurements.
AGING
Aging reduces whole muscle contractile performance, in part due
to a loss of skeletal muscle mass, but also due to reduced mus-
cle quality (Jubrias et al., 1997; Lindle et al., 1997; Lynch et al.,
1999; Morse et al., 2005; Delmonico et al., 2009). This age-related
diminution in muscle contraction tends to affect dynamic more
than isometric function (Lanza et al., 2003; Callahan and Kent-
Braun, 2011; Miller et al., 2013), which suggests skeletal muscle
properties are altered in a manner that maintains higher forces
at slower speeds of movement. Identification of interventions to
halt or reverse age-related alterations in skeletal muscle quantity
and quality, therefore, can help to maintain physical function and
independent living in older adults.
MUSCLE QUALITY
Multiple human studies have examined whether aging alters con-
tractile performance at the single fiber and myofilament levels
with differing results. Findings are generally concordant across
fiber types within an individual study, but age-related adapta-
tions in MHC I and IIA fiber contractile performance (isometric
tension and velocity) vary widely across studies, with some show-
ing decreases (Larsson et al., 1997; Frontera et al., 2000, 2008;
Krivickas et al., 2001; D’Antona et al., 2003; Ochala et al., 2007; Yu
et al., 2007) and others showing that function remains unchanged
or even increases (Frontera et al., 2003; Trappe et al., 2003;
Korhonen et al., 2006; Reid et al., 2012, 2014; Miller et al., 2013).
Notably, longitudinal studies show that single fiber tension and
velocity either increase or remain constant (Frontera et al., 2008;
Reid et al., 2014), suggesting that older adults do not show contin-
ued loss of contractile performance and may, in fact, experience
improved myofilament function as a compensatory mechanism
to offset whole muscle functional decline.
Although single fiber performance results vary widely, myosin
protein function appears to decrease from early (e.g., 20–35
year age range) to the older adult (e.g., 60 years and older).
In single fibers, and especially in MHC IIA fibers, aging low-
ers ATPase (Larsson et al., 1997), slows the time response to
changes in fiber length (Ochala et al., 2006, 2007), as well as
lengthening ton and potentially toff (Miller et al., 2013), indi-
cating slowing of XB kinetics with age. Using isolated myosin,
in vitro motility studies show that MHC I actin sliding veloc-
ity is decreased (Hook et al., 2001; D’Antona et al., 2003) or
unchanged (Canepari et al., 2005) with age, while these same
studies agree that MHC IIA actin sliding velocity is unchanged
(Hook et al., 2001; D’Antona et al., 2003; Canepari et al., 2005).
Thus, in contrast to single fibers, results from studies of isolated
myosin suggest that MHC I has the larger aging response of slow-
ing XB kinetics (as slower velocity is indicative of a longer ton
and/or toff), while MHC IIA is unaffected. These divergent results
between these two assays may be related to their experimental
conditions as single fiber experiments are performed with their
native regulatory protein content and three-dimensional struc-
ture using solutions similar to physiologic conditions, while, in
order to specifically determine myosin’s role in contractile per-
formance, isolated myosin studies remove the myosin from its
fiber structure and are typically performed with unregulated actin
(Hook et al., 2001; D’Antona et al., 2003; Canepari et al., 2005).
Our laboratory (Okada et al., 2008; Miller et al., 2010) and oth-
ers (Thedinga et al., 1999; D’Antona et al., 2003) have similarly
found divergent results when examining myofilament function in
isolated myofilaments preparations vs. chemically-skinned single
fiber preparations, including when examining genetically-altered
animal models (Palmiter et al., 1999; Wang et al., 2013). Based on
this evidence, caution must be exercised when interpreting results
from these different experimental preparations. Nonetheless, with
this caveat in mind, these results collectively suggest that aging
generally decreases XB kinetics.
How would slower XB kinetics alter single fiber contractile
performance? We would predict that the slowing of XB kinetics,
especially longer ton (Miller et al., 2013), should lead to a decrease
in contractile velocity. This conclusion is supported by findings
of an age-related reduction in contractile velocity that occurs in
concert with indications of slower XB kinetics [reduced ATPase
activity (Larsson et al., 1997) and longer time response to changes
in fiber length (Ochala et al., 2006, 2007)]. At the same time that
decreases in XB kinetics reduce velocity, it could have the recip-
rocal effect of increasing tension, as slower XB kinetics appear
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to drive an increase in myofilament stiffness, or improved force
transmission, that leads to higher isometric tension (Miller et al.,
2013). Similarly, slower XB kinetics in older adults occur with an
increase in single fiber stiffness, although their overall isometric
tension was reduced (Ochala et al., 2006, 2007), which could be
explained by reductions in the overall number of XBs secondary
to decreased myosin protein expression (D’Antona et al., 2003).
Collectively, these studies indicate that the slowing of XB kinet-
ics with age most likely decreases contractile velocity, but may
have the paradoxical effect of improving myofilament stiffness
and isometric tension.
When findings indicate almost any alteration with age is pos-
sible, most noticeable in single fiber contractile performance, this
pattern of differences suggests that factors related to the popu-
lations studied or the methods employed may explain variation
among studies. As the methodology used and experimental con-
ditions are generally standard across studies, variation in the
populations studied likely explains the divergent results across
studies. One potential reason behind these varying results is
differences in physical activity among the populations studied
(Figure 1), a factor that is difficult to control for and has com-
monly not been addressed. Physical activity in older adults is
well-known to alter single fiber contractile properties (Trappe
et al., 2000, 2001; D’Antona et al., 2003, 2007; Frontera et al.,
2003; Parente et al., 2008; Harber et al., 2009; Toth et al., 2012),
with higher levels of daily activity or specific exercise training
regimens tending to reduce or eliminate age-related differences.
Such adaptations are not, however, simply linear throughout the
activity spectrum, as immobilization in older individuals has
been found to increase velocity (D’Antona et al., 2003, 2007),
suggesting that complete loss of weight-bearing activity is char-
acterized by very different adaptations, in keeping with findings
from animal studies (Reiser et al., 1987) and muscle unload-
ing due to short duration spaceflight in humans (Widrick et al.,
1999). Nonetheless, a modulatory role for physical activity with
age would suggest that exercise training maymitigate disability, in
part, through a reduction of the deleterious age-related changes in
myofilaments.
Another potential confounding factor is differences between
men and women in their response to aging. Older women have
been found to generate higher isometric tensions in MHC I and
IIA fibers (Yu et al., 2007; Miller et al., 2013) and have slower con-
tractile velocities in MHC I (Krivickas et al., 2001; Yu et al., 2007)
and IIA (Krivickas et al., 2001) fibers. These results are consis-
tent with the finding of slower XB kinetics being more prominent
in both of these fiber types in older women (Miller et al., 2013),
as we predict slower kinetics would increase tension and decrease
velocity. Sex has also been found to have an effect on force pro-
duction based upon fiber size, as MHC I and IIA fibers with
large CSAs produce less force in women compared to men and
MHC I fibers with small CSAs produce more force in women
(Frontera et al., 2000). However, other studies have found no
statistical differences in the single fiber contractile properties of
isometric tension and velocity between older men and women
(Trappe et al., 2003; Krivickas et al., 2006), with individual labo-
ratories sometimes showing differing results from study to study
(Krivickas et al., 2001, 2006). Such variation among studies may
reflect differences in other subject characteristics (e.g., physical
activity), the number of fibers being examined [i.e., only 7 MHC
IIA fibers in older women (Trappe et al., 2003)], or sample sizes
as studies not observing sex differences were smaller (n = 16–24)
than those observing differences (n = 24–38). Notably, a large
cross-sectional study (n = 71) indicates older mobility-limited
females produce higher isometric tension in MHC IIA fibers
compared to males (Reid et al., 2012), although a three-year lon-
gitudinal study (n = 16) from the same laboratory found no sex
effects on single fiber performance between healthy and mobility-
limited older adults (Reid et al., 2014). Regardless of the reason for
variation among studies, these findings raise the possibility that
sex differences in myofilament function may contribute to the
discrepancies in age-related changes in single fiber performance
among studies.
MUSCLE QUANTITY/STRUCTURE
In general, studies using individual skinned fibers find no change
in MHC I and IIA CSA with age (Frontera et al., 2000, 2003,
2008; Ochala et al., 2007; Hvid et al., 2010; Reid et al., 2012,
2014), although some have found decreases in MHC I (D’Antona
et al., 2003), IIA (Larsson et al., 1997), or both (Korhonen et al.,
2006). CSA also decreases with inactivity in both fiber types
(D’Antona et al., 2003). Moreover, CSA has either no (Frontera
et al., 2000; Reid et al., 2012, 2014) or varied response to aging in
men vs. women, with older men having larger CSAs than young
in MHC I fibers (Miller et al., 2013) and older men (Yu et al.,
2007) or women (Trappe et al., 2003; Miller et al., 2013) hav-
ing smaller CSAs than their young counterparts. An advantage
of CSA measurements in single skinned fibers is that they are
typically performed at the experimental sarcomere length (usu-
ally ∼2.50–2.75μm), providing a consistent standard across fiber
types and age groups. However, one caveat to the skinned fiber
preparation is that it undergoes swelling, which may complicate
age comparisons. When CSAmeasurements are determined from
both skinned fibers used for contractile performance and fresh
frozen preparations via histochemistry within the same group of
volunteers, the two techniques can produce different results, with
histochemistry results finding no change in MHC I fibers with
age and decreasing in MHC IIA with age (Korhonen et al., 2006;
Miller et al., 2013; Callahan et al., 2014a). However, recent studies
suggest that age-related differences in skinned human single mus-
cle fibers are comparable to differences observed with fresh frozen
preparations (Hvid et al., 2011). Parenthetically, studies in genetic
animal models (Blaauw et al., 2009), where muscle fiber protein
content is dramatically altered (e.g., 50% hypertrophy in 3 weeks
due to activation of Akt signaling) showed disparate CSA results
between skinned and fresh frozen preparations, suggesting that
variation in the degree of swelling may occur with alterations in
fiber protein content, urging caution with this approach. Studies
examining whole vastus lateralis muscle indicate that the age-
related reduction in muscle size is due to fibers being lost and
a decrease in CSA, especially in MHC II fibers (Lexell et al., 1988;
Lexell and Downham, 1991; Lexell, 1995). In contrast, a recent
metaanalysis, which did not include skinned fiber results, indi-
cates CSA is unchanged with age, but is larger with higher physical
activity levels (Gouzi et al., 2013). Thus, the variation in CSA
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with age between the various studies may be due to other con-
founding factors. Overall, these results indicate that CSA with age
either remains unchanged or decreases in MHC II fibers, with
alterations possibly affected by sex. Despite potential changes in
CSA, recent data indicates that the amount of myofilaments as
well as their general structure and stoichiometry is unaltered with
age or sex (Callahan et al., 2014a). However, studies do indicate
age-related changes in post-translational modifications, such as
decreased phosphorylation of the fast isoform of the regulatory
myosin light chain (Gelfi et al., 2006; Miller et al., 2013), and in
gene expression of protein isoforms, such as an increased gene
expression of tropomyosin 2 (Roth et al., 2002). These types of
alterations have not been commonly examined in human, but
may play a role in functional adaptations as they can affect XB
performance.
As the MHC isoform distribution and content can alter con-
tractile performance, several studies have examined the age-
related changes in these properties. MHC isoform distribution
remained unchanged in longitudinal studies (Frontera et al.,
2008) and when physical activity was matched between young
and older volunteers (D’Antona et al., 2007; Miller et al., 2013).
However, activity level is generally thought to modify MHC iso-
form distribution, with lower activity causing a shift toward a
faster phenotype, or an increase in MHC IIX (D’Antona et al.,
2003, 2007), and higher activity causing a shift toward a slower
phenotype, or an increase in MHC I (Korhonen et al., 2006;
D’Antona et al., 2007). MHC content also remained unchanged
in studies matching for physical activity levels (Trappe et al., 2003;
Miller et al., 2013) and decreases with reductions in physical activ-
ity and immobilization (D’Antona et al., 2003). Altogether, these
studies indicate that the amount or types of MHC are not altered
by age, but can be changed in older adults based upon their
habitual level of exercise.
HEART FAILURE
Heart failure represents the final common pathway for most
chronic cardiovascular disease, and is characterized by an inabil-
ity of the heart to pump blood to meet the metabolic demands
of the body, or that it can only do so at elevated filling pressures.
Accordingly, exercise intolerance is the hallmark symptom of the
disorder, leading to high rates of disability (Pinsky et al., 1990).
Although reduced cardiac contractile performance undoubtedly
contributes to reduced functional capacity, changes in skele-
tal muscle physiology, including muscle atrophy, weakness and
reduced oxidative capacity are well-accepted contributors (Zizola
and Schulze, 2013). Amore complete understanding of the mech-
anisms causing muscle dysfunction, therefore, is important for
identifying appropriate countermeasures to maintain or improve
the whole muscle performance and, in turn, reducing disability in
these patients.
MUSCLE QUANTITY/STRUCTURE
Skeletal muscle atrophy in patients with end-stage heart fail-
ure has been recognized for decades (Pittman and Cohen, 1964)
and studies have identified reductions in single muscle fiber
size in patients, especially in MHC IIA fibers (Mancini et al.,
1989; Massie et al., 1996; Szentesi et al., 2005), although others
have shown that CSA remains unchanged in stable, ambula-
tory heart failure patients (Sullivan et al., 1990; Schaufelberger
et al., 1995, 1997; Miller et al., 2009). Prior results of reduced
CSA may be partially explained by muscle disuse-related atro-
phy, as few studies have controlled for this confounding factor,
or because patients were studied shortly following hospitalization.
Interestingly, human studies (Toth et al., 2005; Miller et al., 2009),
along with animal models (Van Hees et al., 2007), have shown
a phenotype of reduced myosin content/functional XB number
at the whole tissue and single fiber levels per unit protein or
fiber CSA using biochemical (gel electrophoresis) and mechan-
ical (rigor stiffness) measurements, and this loss is observed
in patients even when compared to activity-matched controls
(Miller et al., 2009). These studies have also suggested that there
was no specific reduction in actin protein or thin filament con-
tent with heart failure (Miller et al., 2009). At the ultrastructural
level, myosin loss could present as a decreased number of thick
filaments, shortened thick filaments or a combination of both
adaptations. However, no change in either thick-to-thin filament
stoichiometry or thick filament length has been found (Miller
et al., 2009). Based on this evidence, we hypothesized that myosin
was lost at random throughout the thick filament, which would
agree with studies that indicate remodeling of the thick fila-
ments takes place by removing and replacing myosin molecules
at random throughout the length of the filament (Wenderoth and
Eisenberg, 1987; Franchi et al., 1990). Further confirmation of
this pattern of thick filament adaption in heart failure will be
difficult, as the resolution of current microscopic approaches is
insufficient to rigorously test this hypothesis. Nonetheless, the
loss of myosin from muscle fibers has clear functional relevance
(discussed below).
On a more macroscopic level, heart failure has long been asso-
ciated with a shift in skeletal muscle fiber type toward a more
fast-twitch phenotype (Mancini et al., 1989; Vescovo et al., 1996;
Sullivan et al., 1997; Toth et al., 2005). A shift in MHC isoform
distribution of this nature could contribute to reduced exercise
tolerance given the differing oxidative potential of MHC I and
II fibers and this has been demonstrated in patients (Vescovo
et al., 1998). However, this pattern of isoform distribution is also
emblematic of muscle disuse (Narici and De Boer, 2011) and
heart failure patients expend about half as many calories in voli-
tional activity as healthy controls (Toth et al., 1997), suggesting
that this adaptation might be due to inactivity accompanying
the disease, rather than the disease process itself. This appears
to be the case, as we have recently found no alteration in mus-
cle MHC protein isoform expression in patients when compared
to activity-matched controls (Miller et al., 2009), and others
have shown no differences in MHC isoform expression between
patients and controls matched for peak aerobic fitness (Mettauer
et al., 2001). There is limited information regarding shifts in
isoform expression of other myofilament proteins. One study
showed a shift in myosin light chain and troponin T, I, and C
toward a slow-twitch isoform distribution in diaphragm mus-
cle in heart failure patients commensurate with a shift in MHC
expression toward the MHC I isoform (Tikunov et al., 1996).
However, unlike peripheral skeletal muscle, the diaphragm mus-
cle undergoes different functional adaptations (i.e., increased
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work due to increased pulmonary resistance vs. muscle dis-
use in peripheral skeletal muscle). In peripheral skeletal muscle,
myosin light chain isoform distributions in MHC IIA single
fibers were found to show a trend toward greater expression
of MLC 1f in heart failure patients (Miller et al., 2010), but
this was not associated with differences in single fiber function.
Although an indirect measure, an alteration in Ca2+ sensitivity
was noted in MHC IIA fibers, which could reflect adaptations in
actin-associated regulatory proteins, albeit this was not directly
measured.
MUSCLE QUALITY
Independent of variation in muscle size, numerous studies have
suggested that there are reductions in skeletal muscle contractile
function at the whole muscle [i.e., tissue level (Harrington et al.,
1997; Toth et al., 2010)], suggesting decreased intrinsic function
of muscle that may be due to myofilament deficiencies, impaired
excitation-contraction coupling (Reiken et al., 2003) or a com-
bination of the two. Studies in humans and animal models over
the past 5–10 years have shed light on the possible involvement of
myofilaments in these contractile deficits.
The most prominent quantitative/structural change that
would be predicted to contribute to strength losses per unit
muscle size is a loss of MHC, which should decrease the total
number of functional myosin heads, causing a reduction in sin-
gle fiber isometric tension. Indeed, recent studies have found
reduced tension in both in MHC I and IIA fibers from heart fail-
ure patients (Szentesi et al., 2005) and in experimental models
(Van Hees et al., 2007). However, studies from our laboratory,
in which heart failure patients were matched for both age and
physical activity level, unlike prior studies (Szentesi et al., 2005),
found no diminution in single fiber tension (Miller et al., 2010),
arguing that prior results of reduced tension with heart fail-
ure were explained more by muscle disuse and/or aging than by
heart failure per se. The question then becomes: how is tension
maintained in the face of a reduction in the overall amount of
myosin/functional XBs? We found that XB kinetics were slowed,
manifested most prominently as a longer ton, in MHC I and IIA
fibers, in patients compared to controls (Miller et al., 2010), a
result that has also been observed in animal models of heart fail-
ure (Van Hees et al., 2007). This reduction in XB kinetics, if not
compensated for by an increase in toff, would lead to an increase
in residence time of myosin in the strongly-bound state and, in
turn, more myosin heads bound to actin as a function of total
myosin cycle time. This is indeed the case, as we found no evi-
dence for a reduction in strongly-boundmyosin-actin XBs during
maximal Ca2+ activation in heart failure patients using differ-
ent techniques (Miller et al., 2009, 2010). Thus, adaptations in
myosin kinetic properties compensate for the loss of myosin pro-
tein content to preserve isometric contractile strength. In fact,
building off of our findings from myofilament ultrastructural
measures that suggested a random loss of myosin heads along the
length of the thick filament detailed above (Miller et al., 2009), we
recently reported the results of modeling studies which suggest
that this pattern of myosin loss is associated with an increase in
myosin attachment time (Tanner et al., 2014). Thus, we hypoth-
esize that a random removal of myosin from the thick filament
alters the load imparted to a strongly-bound XB causing a length-
ening of ton, leading to a higher duty ratio and higher tension
generation.
Although single muscle fiber tension is maintained, reduc-
tions in myosin kinetics in heart failure patients may not be
without functional consequences. We would predict that reduced
XB kinetics, and increased ton specifically, would reduce con-
tractile velocity (Miller and Toth, 2013). Indeed, recent studies
from our laboratory show that this is the case in MHC IIA fibers,
where lower XB kinetics were associated with decreased single
fiber shortening velocity and, in turn, power output (Callahan
et al., 2014b). Thus, while we found no evidence for decrements
in single fiber tension that would scale to the tissue level to
explain reduced isometric force production (Harrington et al.,
1997; Toth et al., 2010), reduced myosin-actin XB kinetics may
explain reduced muscle power output during dynamic contractile
conditions (Toth et al., 2010). This is noteworthy, as reductions
in lower-extremity power output are a primary determinant of
physical disability (Reid and Fielding, 2012). Thus, alterations in
myofilament properties to yield a reduction in the overall capac-
ity for muscle power output during dynamic activities would
mean that any activity would be performed at greater percent-
age of the muscle’s physiological capacity and, in turn, may be
more fatiguing. In this context, myofilament adaptations may
partially contribute to the subjective sensation of exercise intol-
erance present in heart failure patients, the primary symptom of
the disease.
CANCER
Cancer has well-known effects on skeletal muscle that have been
the subject of intense investigation for decades. The most notable
effects of cancer are to reduce overall muscle mass secondary to
the profound wasting that occurs with the disease [i.e., cancer
cachexia (Fearon et al., 2012)], which has, by far, been studied
most extensively. However, atrophy is usually confined to cer-
tain cancers (e.g., lung, pancreatic, head, and neck) or the later
stages of the disease. In contrast, estimates suggest that up to
90% of patients experience subjective functional deficits, mani-
fested most notably as cancer-related fatigue (Cella et al., 2001).
Subjective fatigue is a complex psycho-physiological construct,
but likely has some roots in reductions in physiological capac-
ity and a recent study suggests that this may relate, in part, to
alterations in myofilament biology (Toth et al., 2013).
MUSCLE QUANTITY/STRUCTURE
Cancer is primarily thought to influence skeletal muscle through
its ability to promote muscle atrophy, and has recently been
reviewed in detail (Fearon et al., 2012). Despite the well-known
atrophic effects of cancer, there are surprisingly few studies that
have examined its effects on single muscle fiber size in humans
(Weber et al., 2009), although recent work confirms that the
atrophy observed at the tissue level extends to the cellular level
(Toth et al., 2013). Although profound reductions in the overall
amount of contractile tissue occur, recent ultrastructural studies
suggest that atrophy is characterized by stoichiometric reduc-
tions in the myofilament content relative to fiber CSA (Toth
et al., 2013). In contrast to these anatomic measurements, studies
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that have evaluated myofilament protein content using biochem-
ical approaches in both pre-clinical models (Acharyya et al.,
2004) and patients (Eley et al., 2008) have suggested that atro-
phy in cancer is associated with a selective loss of the contractile
protein myosin, with relative preservation of other contractile
proteins. If present, one would predict that such an adaptation
would diminishmuscle contractile force production (Geiger et al.,
2000) by decreasing the number of available myosin heads to
form strongly-bound XBs. However, more recent studies in the
same animal models, as well as patients with cancer, have found
no reduction in myosin protein content (Cosper and Leinwand,
2012; Toth et al., 2013). In fact, one study showed that prior find-
ings of a select loss of myosin were likely a methodological artifact
(Cosper and Leinwand, 2012). Notably, MHC isoform distribu-
tion also remains unchanged with cancer (Toth et al., 2013). Thus,
from a quantitative perspective, cancer reduces overall muscle
function primarily through its effect to decrease the overall mass
of myofilament protein in muscle via simple atrophy, seemingly
without selective loss of the major myofilament proteins myosin
and actin. This gross loss of contractile tissue manifests func-
tionally as muscle weakness, which undoubtedly contributes to
physical disability in cancer patients.
MUSCLE QUALITY
Because of the prevalence of muscle atrophy in the cancer pop-
ulation, it is difficult to discern whether impaired muscle perfor-
mance is related to a fundamental defect in contractility, or relates
instead to the loss of the contractile components (i.e., myofila-
ments). In humans, to our knowledge, only three studies have
simultaneously evaluated skeletal muscle contractile function and
muscle size, with one study showing that muscle weakness was
completely explained by atrophy (Weber et al., 2009), whereas
the others suggested that there was a reduction in intrinsic con-
tractility, or force production per unit muscle size (Stephens
et al., 2012; Toth et al., 2013). Further reinforcing the notion
of intrinsic contractile dysfunction, one recent study (Gallagher
et al., 2012) reported that surgical removal of the tumor in col-
orectal cancer patients increased knee extensor isometric torque
(∼20%; personal communication with the authors) after a mean
follow-up of 8 months despite reductions in body weight (and
presumably muscle mass). Thus, from whole muscle measure-
ments, the balance of evidence suggests that cancer is associ-
ated with some degree of intrinsic skeletal muscle contractile
dysfunction.
Evidence to support intrinsic contractile dysfunction in cancer
patients comes from studies at the single fiber level (Toth et al.,
2013). We recently found evidence for contractile dysfunction
in both MHC I and IIA fibers. In MHC IIA fibers, a reduction
(∼15%) in isometric tension was observed in cancer patients
compared to fibers from healthy controls, which has been corrob-
orated by a recent study from another laboratory (Taskin et al.,
2014). These results provide strong evidence for intrinsic contrac-
tile dysfunction in cancer. Molecular level functional assessments
suggested a potential mechanism for decreased isometric tension;
namely, that the number of strongly-attached myosin-actin XBs
was reduced in cancer patients, as single fiber force production
is proportional to the number of strongly-bound XBs during
Ca2+ activation. In addition to reduced tension in MHC IIA
fibers, myosin-actin cross-bride kinetics were reduced in MHC
I fibers (Toth et al., 2013). Specifically, myosin attachment time
was increased in MHC I fibers from cancer patients compared
to controls. From a functional standpoint, we would predict that
this reduction in XB kinetics could decrease single fiber power
output, as an increase in myosin attachment time would decrease
single fiber contractile velocity (Piazzesi et al., 2007). Thus, this
molecular level alteration may have functional significance to cel-
lular and tissue level function. In support of this notion, we found
that slower myosin rate of force production, another marker of
reduced myosin-actin XB kinetics, were related to reduced knee
extensor torque (Toth et al., 2013).
The mechanisms underlying intrinsic skeletal muscle contrac-
tile dysfunction with cancer are unclear. Data from whole muscle
studies, in which knee extensor strength was measured before and
after surgical removal of tumors indicates that alterations in func-
tion occur independent of changes in overall muscle size [i.e.,
improved function occurred in the setting of continued weight,
and presumably muscle, loss (Stephens et al., 2012)]. In other
words, intrinsic contractile dysfunction is not dependent upon
or related to the atrophy process. One potential mediator that
could explain contractile dysfunction is oxidative stress, as can-
cer is associated with increased oxidative stress in skeletal muscle
(Barreiro et al., 2005; Ramamoorthy et al., 2009; Marin-Corral
et al., 2010). Increased oxidant activity could promote contractile
dysfunction via post-translational modification of myofilament
proteins (Reid and Moylan, 2011). Indeed, pre-clinical studies
that have treated skinned muscle fibers with oxidants have shown
that oxidative modification of myofilament proteins reduces ten-
sion, velocity, myosin ATPase/XB kinetics and strongly-bound
XBs (Wilson et al., 1991; Galler et al., 1997; Perkins et al.,
1997; Callahan et al., 2001; Heunks et al., 2001; Coirault et al.,
2007), effects that resemble the myofilament functional phe-
notype we observe in cancer patients (Toth et al., 2013). In
support of this mechanism, we recently found that treatment
of human single MHC I muscle fibers with N-ethylmaleimide
(NEM) slowed XB kinetics, as evidenced by increased myosin
attachment time. In fact, by down-titrating the NEM, which
modifies protein thiol groups, a common target of cellular oxi-
dants, we showed that we could reduce myosin kinetics with no
change in single fiber tension (Callahan et al., 2014b), a pheno-
type that bears remarkable resemblance to the adaptations we
observed in cancer patients. Additionally, cancer patients exhib-
ited profound mitochondrial rarefaction and remodeling, with
the former being associated with reduced XB kinetics in MHC
I fibers and tending to be related to reduced strongly-bound
XBs in MHC IIA fibers (Toth et al., 2013). Taken together, these
results suggest disruption in mitochondrial biology, and possibly
increased oxidant activity, in the skeletal muscle of cancer patients
may contribute to myofilament dysfunction in both fiber types.
As oxidative stress has also been forwarded as a potential medi-
ator of muscle atrophy in cancer patients (Buck and Chojkier,
1996; Di Marco et al., 2005), our results suggest increased oxidant
activity as a potential common mediator of the complex mus-
cle phenotype of muscle atrophy and contractile dysfunction in
cancer.
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CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
COPD is a lung disorder characterized by progressive airflow
obstruction from inflammation and remodeling of the airways,
which often results from emphysema secondary to cigarette
smoking. Like heart failure, exercise intolerance is the cardinal
symptom, which, along with the obvious contribution of the
primary lung pathology, is thought to be due, in part, to a com-
bination of atrophy and reduced oxidative capacity of skeletal
muscles (Maltais et al., 2014). In fact, some authors have sug-
gested similar pathoetiology of peripheral skeletal muscle adap-
tations in the two conditions (Gosker et al., 2000). The majority
of research on peripheral skeletal muscle adaptations in COPD
patients has focused on oxidative adaptations and atrophy and, to
our knowledge, no study has specifically characterized myofila-
ment function. In contrast, a considerable amount of work has
been done examining diaphragm muscle myofilament protein
expression and function, including two excellent studies evalu-
ating single fiber function (Ottenheijm et al., 2005; Stubbings
et al., 2008). This focus is logical considering the importance
of respiratory muscle function in COPD. However, respiratory
and peripheral skeletal muscle undergo very different adapta-
tions in response to COPD (Levine et al., 2013), owing to the
different pathophysiological demands—increased airway resis-
tance necessitating increased muscle work in respiratory muscles
and decreased muscle use owing to reduced physical activity in
peripheral skeletal muscles (Watz et al., in press). For the purposes
of the current review, we have focused primarily on studies that
have evaluated myofilament adaptations in peripheral skeletal
muscles.
MUSCLE QUANTITY AND STRUCTURE
Muscle atrophy in patients with COPD has largely been inferred
from cross-sectional studies comparing whole muscle size in
patients to non-diseased controls, with findings of reduced
muscle size in COPD patients that is exacerbated with more
severe disease (Remels et al., 2013; Maltais et al., 2014). These
results are corroborated at the cellular level, with several stud-
ies showing decreased single muscle fiber size in COPD patients
(Whittom et al., 1998; Gosker et al., 2002; Fermoselle et al., 2012).
Interestingly, a recent study showed a similar rate of decline in
lean tissue mass (a proxy of muscle mass) in individuals with
COPD vs. non-diseased controls (Van Den Borst et al., 2011),
suggesting that some differences in muscle fiber size may relate
to early adaptations to cigarette smoking and/or could be a man-
ifestation of the population that goes on to develop COPD.
Regardless of the etiology, a loss of muscle fiber size would have
clear relevance to decreased functional capacity and contribute to
disability.
Numerous studies have suggested that that there is a skele-
tal muscle fiber type shift in COPD toward a more fast-twitch
phenotype, manifested as a reduced relative expression of MHC
I vs. MHC II fiber types (Gosker et al., 2007), with accompa-
nying shifts in myosin light chain isoforms (Satta et al., 1997).
Some studies have failed to find such a fiber type shift in deltoid
muscle (Gea et al., 2001), arguing that fiber type adaptations to
COPD in the lower extremity musculature may reflect the effects
of muscle disuse. Thus, similar to heart failure, as discussed above,
this fiber type adaptation may simply be function of chronic
disuse in COPD patients, rather than an effect of the disease
process per se.
MUSCLE QUALITY
As mentioned above, there are few studies that have directly mea-
sured muscle fiber function in COPD patients and nearly all
of these have evaluated diaphragm muscle (Levine et al., 2003;
Ottenheijm et al., 2005; Stubbings et al., 2008). There has been
one study that evaluated function of isolated vastus lateralis mus-
cle fiber bundles in COPD patients and controls (Debigare et al.,
2003), which found no differences in maximal isometric tetanic
contraction or adaptation in the force-frequency response, albeit
the latter tended to be shifted to the right in COPD patients.
Importantly, this study utilized an excitable muscle preparation,
meaning that the contractile response reflects the effects of COPD
on both myofilaments and Ca2+ release dynamics. Thus, the
altered force-frequency response could be explained by alterations
in Ca2+ release/reuptake, myofilament Ca2+ sensitivity or a com-
bination of these changes. Caution is urged in interpreting this
study, however, as the viability of an excitable muscle fiber bundle
preparation is questionable.
In diaphragm muscle fibers, early studies in two COPD
patients showed reduced single fiber tension (Levine et al., 2003).
Studies in a larger population (n = 8) similarly showed reduced
single fiber tension in MHC I and IIA fibers from COPD patients
compared to controls and this reduction was attributed pri-
marily to a reduction in myosin protein content (Ottenheijm
et al., 2005). Moreover, the rate constant for force redevelop-
ment following a following a rapid length decrease, a proxy
measure of cross-bridge kinetics, was slower in COPD patients. A
more recent study has further corroborated slowed cross-bridge
cycling, as the ATPase rate of MHC I and IIA fibers was lower
in COPD patients (Stubbings et al., 2008), although this study
did not observe altered single fiber tension. Moreover, Stubbings
et al. found reduced maximal power production from MHC IIA
fibers in COPD patients. Collectively, these decrements in res-
piratory muscle function could limit pulmonary function and,
in turn, contribute to exercise intolerance, the hallmark symp-
tom of COPD and a clear contributor to disability. How these
adaptations in myofilament function in diaphragm fibers reflect
peripheral skeletal muscle myofilament adaptations, however, is
unclear. Although there are some myofilament adaptations with
COPD that generalize to striated skeletal muscle [e.g., myofila-
ment protein oxidation (Caron et al., 2009)] and could reasonably
be expected to impact function, as discussed above in regards to
cancer-related myofilament dysfunction (Callahan et al., 2014b),
studies on skinned single fibers from peripheral muscles of COPD
patients are needed to confirm involvement of the myofilaments
in reduced peripheral muscle contractile function that is also
believed to contribute to disability (Maltais et al., 2014).
DISUSE
The specific adaptations of muscle to acute or chronic disuse are
particularly interesting to physiologists and clinicians due to: (1)
the profound effects of inactivity on multiple aspects of mus-
cle size, protein composition and function and (2) the relevance
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of disuse for skeletal muscle adaptations to numerous clinically-
relevant conditions (e.g., acute hospitalization, surgical recovery,
chronic disease, etc.). Because chronic physical inactivity is both a
risk factor and consequence of aging- and disease-related changes
in skeletal muscle, it is difficult to disentangle the relative influ-
ence of aging/disease vs. disuse. As the effects of disuse have been
studied rather extensively in healthy, younger humans (Adams
et al., 2003; Narici and De Boer, 2011), this review will focus on
adaptations to muscle disuse in older adult humans, which has
received increased attention recently. Before beginning this dis-
cussion, we need to define acute and chronic disuse. As there
are no widely-accepted definitions for the length of either acute
or chronic or any biological hallmark that serves as a tempo-
ral cut-point, we have decided to put these into the context
of clinically-relevant events that may impose disuse upon older
adults. Acute periods of disuse occur with the onset or exacer-
bation of disease or other clinical events (e.g., surgery) and their
subsequent period of convalescence. These can last for a few days,
but may persist for several months (e.g., 3–6 months), as in the
case of recovery from surgical interventions (e.g., joint replace-
ment, hip fracture, coronary artery bypass graft surgery), with the
defining characteristic being that muscle use patterns eventually
return to “normal,” pre-event levels. In contrast, chronic muscle
disuse is marked by a failure to re-establish prior levels of muscle
use, with accommodation at a lower absolute level of muscle use.
Therefore, by definition, this type of disuse lasts for years andmay
never be fully remediated.
MUSCLE QUANTITY/STRUCTURE
Muscle disuse is known to cause marked reductions in muscle
CSA in healthy young individuals (Adams et al., 2003; Narici
and De Boer, 2011) and recent studies suggest that bed rest-
inducedmuscle disuse is similarly associated with lower extremity
muscle atrophy (−6%) in older adults (Kortebein et al., 2007).
More recent studies that imposed disuse using leg casting in
older adult men for a shorter period of time (4 d) have shown
more robust atrophy (∼10% reduction in both MHC I and II
fiber types) compared to baseline when single muscle fiber CSA
was evaluated (Suetta et al., 2012). Interestingly, when casting
is maintained for 14 d, the degree of atrophy did not increase
dramatically (∼13% reduction) and this differs from younger
men, who showed a more marked reduction in single muscle
fiber CSA (−20%) (Suetta et al., 2012). Thus, disuse-related atro-
phy may be attenuated in older adults over time. In general, this
atrophy was evenly distributed between MHC I and II fibers in
shorter-term studies (4–5 d), but was more pronounced in MHC
II fibers over longer periods (14 d) (Suetta et al., 2012; Wall et al.,
2014).These data suggest that, like their younger counterparts,
older adults appear to have a relatively robust atrophy response
to experimentally-induced, acute muscle disuse. Additionally, one
study showed that myosin protein content of single muscle fibers
was profoundly reduced (−44% in MHC I and −31% in MHC
IIA fibers, albeit differences in MHC II fibers did not reach sig-
nificance) in two older adult men who were studied 3 months
following leg immobilization for clinical purposes (D’Antona
et al., 2003), but corroboration of these findings or character-
ization of the anatomical phenotype of myosin loss is lacking.
Despite changes in muscle size, short term immobilization did
not alter myosin isoform distribution (Hvid et al., 2010), while
longer immobilization specifically increased MHC IIX expression
(D’Antona et al., 2003).
Few studies have explored the effects of chronic muscle dis-
use on skeletal muscle size and structure in humans, primar-
ily because experimentally-imposed disuse for extended periods
of time on humans of any age would be deemed unethical.
However, one could argue that this type of muscle disuse is
very relevant to the muscle adaptations that occur in disease
states (e.g., heart failure, COPD, etc.), where activity levels are
lower than their non-diseased counterparts (Toth et al., 1997;
Watz et al., in press). To study chronic disuse, several laborato-
ries have evaluated patients with osteoarthritis, where physical
inactivity is chronically depressed due to joint pain. If patients
are selected to be free of other confounding pathologies, these
patients could be considered a model of the effects of chronic
disuse on skeletal muscle. Studies have shown that these patients
have lower (∼9%) quadriceps CSA in their limb with osteoarthri-
tis compared to their unaffected limb (Suetta et al., 2007), and
a greater degree of atrophy compared to non-diseased controls
(Callahan et al., 2014b). Moreover, at the cellular level, there
was profound atrophy (−14 to 32% depending on fiber type)
in muscle fibers. Here again, the extent of atrophy is greater
when examined at the single fiber vs. the tissue level. To date,
no study has reported the effects of either acute or chronic mus-
cle disuse on myofilament ultrastructure or other sub-cellular
components.
MUSCLE QUALITY
Skeletal muscle performance is impaired with disuse in younger
healthy adults, reflected in reduced whole muscle force and power
production (Narici and De Boer, 2011), and this is similarly
observed in older healthy adults in response to short periods
of bed rest (Kortebein et al., 2008). That these changes may be
associated with adaptations in myofilament function is suggested
by several recent studies showing that chemically-skinned, single
muscle fiber contractile function is impaired in older adults with
acute muscle disuse. Single fiber tension after 4 and 14 days of
leg casting is reduced similarly in young and older men in both
MHC I and IIA fibers (Hvid et al., 2011, 2013), although reduc-
tions in MHC I fibers did not reach significance in response to
14 d of disuse. There were differential responses in Ca2+ sen-
sitivity in young and older adult men that showed fiber type
differences, with reductions in older men in MHC I and in
young men in MHC IIA fibers, suggesting the possibility for
age-related differences in the adaptations in actin-associated reg-
ulatory proteins. These findings provide important contributions
to our understanding of the effects of acute disuse and encourage
further study of how this combination of physiologic responses
manifest to change in vivo voluntary torque production and
mobility in at-risk populations, particularly as it pertains to acute
hospitalization.
Building on these results, our recent studies suggest the func-
tional effects of chronic disuse vary by sex (Callahan et al.,
2014b). Although we similarly found reductions in single mus-
cle fiber tension in older adults compared to active controls, these
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differences were only apparent in MHC IIA fibers and dissipated
when fibers were evaluated at temperatures closer to in vivo con-
ditions (25◦C), suggesting that the effects of more chronic disuse
on myofilament force production per unit fiber CSA is limited.
In contrast, we found differences in contractile velocity; more
specifically, that contractile velocity was reduced in females, but
actually increased in males with chronic disuse. Perhaps most
importantly, these differences in contractile velocity translated
to reduced single fiber power output in women relative to men.
Greater contractile velocity (and, in turn, power output) in men
was accompanied by faster cross-bridge kinetics, as indicated by a
reduced myosin attachment time and greater rate of myosin force
production, suggesting that adaptations in molecular contractile
function translate to the cellular level.
Do these adaptations in myofilament function at the molecu-
lar and cellular level contribute to the whole muscle phenotype
of reduced power output in the lower extremity musculature?
Extrapolation from the myofilament to the whole muscle level
is difficult, as there are changes in numerous other physiological
systems with disuse that regulate whole muscle torque (Narici and
De Boer, 2011). Recent studies suggest that acute disuse has more
prominent effects in older adults on dynamic muscle contractions
with higher power output when compared to lower power out-
put and isometric contractions (Hvid et al., 2014), which is in
keeping with results in aging studies showing greater impairments
in dynamic muscle contractile function and, in particular, higher
velocity dynamic contractions (Lanza et al., 2003; Callahan and
Kent-Braun, 2011; Miller et al., 2013). This may be explained by
more pronounced slowing of cross-bridge kinetics in older adults,
an adaptation that is larger in older adult women (Miller et al.,
2013). With more chronic disuse, however, there may be compen-
satory adaptations to maintain myofilament contractile function
specifically in men (Callahan et al., 2014b), with women lack-
ing such adaptations. These myofilament adpatations with disuse
may serve to diminish whole muscle deteroration, as recent lon-
gitudinal studies have shown that reductions in whole muscle
function over time are accompanied by improvements in sin-
gle muscle fiber myofilament force, velocity and power output
(Reid et al., 2014). A failure to undergo such myofilament adap-
tations may predispose women to a more rapid development of
disability. Thus, rather than a straight forward relationship of
reduced myofilament function to decreased whole muscle func-
tion and, in turn, disability, variation in compensatory increases
in myofilament function with longer-term disuse may explain a
greater disposition toward lower extremity muscle function and
disability in some individuals. This scenario provides potential
cellular and molecular level mechanisms underlying higher dis-
ability rates in older women (Jette and Branch, 1981) and suggests
that it may be important to consider the sex-specific response to
disuse in men and women to completely characterize the func-
tional phenotype. Notably, all studies examining the effect of
acute disuse have been conducted in men, which makes it diffi-
cult to discern whether sex-specific adaptations are a feature of
both acute and chronic disuse. Nonetheless, these findings show
that myofilament adaptations may play an important role in the
whole muscle and disability phenotypes that accompany muscle
disuse.
CELLULAR/MOLECULAR EFFECTS ONWHOLE MUSCLE
FUNCTION
The contribution of myofilament adaptations to whole mus-
cle contractile dysfunction and, in turn, physical disability with
aging, disease, and disuse is difficult to discern because of
the myriad of physiological systems that regulate whole mus-
cle performance. Despite this multitude of confounding, higher
level regulatory systems, several studies have shown relationships
between myofilament properties and whole muscle performance.
In older adults, a positive, but non-linear, relationship was found
between single fiber and whole muscle tension (Frontera et al.,
2000), indicating that the age-related decrease in single fiber per-
formance may be partially responsible for decrements in whole
muscle function. In our recent work examining young and older
populations matched for physical activity level, although isoki-
netic knee torque was reduced with age, we found no differences
in whole muscle isometric performance or relationships between
isometric performance and single fiber functional parameters.
However, slower XB kinetics and increased single fiber isometric
tension in MHC IIA fibers predicted lower whole muscle isoki-
netic power with aging (Miller et al., 2013). Thus, age-related
myofilament adaptations were correlated with the primary decre-
ment in whole muscle performance with age. Similarly in cancer
patients, reduced whole muscle isometric torque was related to
slower XB kinetics (Toth et al., 2013). Both the cancer and aging
populations also showed a relationship between slower XB kinet-
ics and mitochondrial fractional area or size (Toth et al., 2013;
Callahan et al., 2014a), suggesting the intriguing hypothesis that
maladaptations in cellular energy homeostasis may contribute to
myofilament dysfunction via post-translational oxidative modifi-
cations. Finally, in knee osteoarthritis patients, variation in XB
kinetics in MHC IIA fibers scaled to the cellular level to yield
sex-specific differences in single fiber power output (Callahan
et al., 2014b). These molecular and cellular level differences
were reflected in a similar pattern of differences in isokinetic
torque at the whole muscle (i.e., lower torque in female knee
osteoarthritis patients), albeit these tissue-level differences did
not reach statistical significance, possibly due to our small sample
size and/or sex-specific effects of pain-induced neural inhibition
associated with knee osteoarthritis. Although preliminary, these
studies collectively demonstrate that alterations at the molecular
and cellular levels generally scale to the tissue level, suggesting
that adaptations in myofilament protein expression and func-
tion may partially explain reductions in muscle function and lead
to greater rates of physical functional disability with aging and
disease.
SUMMARY
Aging, disease, and disuse alter single fiber and myofilament
structure and function, although the changes vary depend-
ing upon the specific disease/physiological condition and sex.
Structurally, the most significant changes were the loss of myosin
content in heart failure patients and the general loss of CSA
in a number of conditions (Table 1). Functionally, the parame-
ter that was consistently changed with these conditions was XB
kinetics (Table 2). Although XB kinetics tend to decrease in most
instances, reductions are dependent upon sex and fiber type, with
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Table 1 | Summary of structural changes in single fiber and
myofilament structure with aging, disease, and disuse.
Structure Aging Heart failure Cancer Disuse
Ultrastructure ↔ ↔ ↔ n.a.
MHC content ↔ ↓ ↔ ↔
MHC isoform phenotype ↔ ↑ ↔ ↔ ↑ ↔
Cross-sectional area ↔ ↓ ↔ ↓ ↔ ↓ ↔ ↓
↑, increase/faster; ↔, no change; ↓, decrease/slower; n.a., not available.
Ultrastructure includes thick filament length, thick-to-thin filament ratio, and
myofibrillar volume fraction; MHC, myosin heavy chain.
Table 2 | Summary of functional changes in single fiber and





Cross-bridge kinetics ↓ ♀ > ♂ ↓ ↓ MHC I
↔ MHC IIA
↓ MHC I of ♀
↑ MHC IIA of ♂
SINGLE FIBER LEVEL
Isometric tension ↑ ↔ ↓ ↔ ↓ ↔ ↓ ↔ ↓
Contractile velocity ↑ ↔ ↓ ↓ * ↓ * ↔ MHC I
↑ MHC IIA of ♂
↓ MHC IIA of ♀
↑, increase/faster; ↔ , no change, ↓, decrease/slower, ♂, male, ♀, female,
>, greater than; *predicted from XB kinetic differences.
chronic muscle disuse in MHC IIA fibers in older men being
the exception to the rule. Several studies have found relation-
ships between cellular and molecular level myofilament function
and whole muscle function (Frontera et al., 2000; Miller et al.,
2013; Toth et al., 2013), underscoring their potential impor-
tance. However, the effects of each condition on function at the
molecular, cellular and whole muscle levels become less clear
when examined across multiple studies within each condition.
This is most clearly evident in variation in myofilament func-
tion with aging, where data suggest that single fiber tension
and velocity increase, remain unchanged, and decrease with age.
We posit that such variation is due to the modifying effects of
confounding factors, such as the habitual activity level and sex
distribution of the populations studied, which have not com-
monly been accounted for in experimental designs or statistical
analyses. While integrated myofilament function has been eval-
uated in the context of single muscle fiber function, sometimes
extending to the cross-bridge level, few studies have interrogated
the specific changes in myofilament protein, expression and/or
post-translational modification might be accounting for these
adaptation. Overall, these findings indicate that a more thorough
understanding of the myofilament adaptations to aging, disease,
and disuse in both sexes would assist with the development of
preventative and rehabilitative interventions to improve muscle
function and, in turn, decrease functional disability in older men
and women.
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